- Home
- NAMS vs RXRX Comparison
NAMS vs RXRX Comparison
Compare NAMS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- RXRX
- Stock Information
- Founded
- NAMS 2019
- RXRX 2013
- Country
- NAMS Netherlands
- RXRX United States
- Employees
- NAMS N/A
- RXRX N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- NAMS Health Care
- RXRX Health Care
- Exchange
- NAMS Nasdaq
- RXRX Nasdaq
- Market Cap
- NAMS 2.9B
- RXRX 2.4B
- IPO Year
- NAMS N/A
- RXRX 2021
- Fundamental
- Price
- NAMS $25.07
- RXRX $5.77
- Analyst Decision
- NAMS Strong Buy
- RXRX Buy
- Analyst Count
- NAMS 9
- RXRX 5
- Target Price
- NAMS $41.00
- RXRX $7.00
- AVG Volume (30 Days)
- NAMS 843.1K
- RXRX 24.9M
- Earning Date
- NAMS 08-06-2025
- RXRX 08-05-2025
- Dividend Yield
- NAMS N/A
- RXRX N/A
- EPS Growth
- NAMS N/A
- RXRX N/A
- EPS
- NAMS N/A
- RXRX N/A
- Revenue
- NAMS $64,006,000.00
- RXRX $64,596,000.00
- Revenue This Year
- NAMS N/A
- RXRX $19.96
- Revenue Next Year
- NAMS $73.09
- RXRX $61.39
- P/E Ratio
- NAMS N/A
- RXRX N/A
- Revenue Growth
- NAMS 762.15
- RXRX 30.14
- 52 Week Low
- NAMS $14.06
- RXRX $3.79
- 52 Week High
- NAMS $27.29
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- NAMS 61.96
- RXRX 53.41
- Support Level
- NAMS $24.73
- RXRX $5.41
- Resistance Level
- NAMS $25.80
- RXRX $5.82
- Average True Range (ATR)
- NAMS 1.33
- RXRX 0.32
- MACD
- NAMS 0.17
- RXRX -0.04
- Stochastic Oscillator
- NAMS 83.46
- RXRX 52.78
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.